نتایج جستجو برای: Codon 12 and 13

تعداد نتایج: 16938062  

Background & objective: KRAS mutations are reported in many types of cancers including pancreas, lung, colon, breast, and gastric (GC). High frequency of KRAS mutation is observed in the pancreas, colon, and lung cancers; they commonly arise in codon 12 and 13 of exon 2. Due to the lack of information about the frequency of KRAS</...

Background: Ovarian carcinoma is one of the leading causes of cancer-related death among females. K-ras codon 12 mutations are commonly occurring mutations in different types of cancers and leads to resistance against anti-EGFR therapeutics. Hence, determination of mutations in k-ras gene is crucial for predicting response to anti-EGFR therapies. This study aimed to evaluate the prevalence of k...

2017
Stéphane Renaud Francesco Guerrera Joseph Seitlinger Lorena Costardi Mickaël Schaeffer Benoit Romain Claudio Mossetti Anne Claire-Voegeli Pier Luigi Filosso Michèle Legrain Enrico Ruffini Pierre-Emmanuel Falcoz Alberto Oliaro Gilbert Massard

INTRODUCTION The utilization of molecular markers as routinely used biomarkers is steadily increasing. We aimed to evaluate the potential different prognostic values of KRAS exon 2 codons 12 and 13 after lung metastasectomy in colorectal cancer (CRC). RESULTS KRAS codon 12 mutations were observed in 116 patients (77%), whereas codon 13 mutations were observed in 34 patients (23%). KRAS codon ...

Objective(s): Dietary phytate is known to protect against azoxymethane (AOM)-induced preneoplastic lesions.  The present study was designed to determine whether dietary phytate affects mutation frequency in colon epithelial cells challenged with azoxymethane in vivo, through lowering the formation of O6-methyl guanosine (O6-MeG) and 8-hydroxy deoxyguanosine (8-OHdG) ad...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2012
Yu Imamura Teppei Morikawa Xiaoyun Liao Paul Lochhead Aya Kuchiba Mai Yamauchi Zhi Rong Qian Reiko Nishihara Jeffrey A Meyerhardt Kevin M Haigis Charles S Fuchs Shuji Ogino

PURPOSE To assess prognostic roles of various KRAS oncogene mutations in colorectal cancer, BRAF mutation status must be controlled for because BRAF mutation is associated with poor prognosis, and almost all BRAF mutants are present among KRAS wild-type tumors. Taking into account experimental data supporting a greater oncogenic effect of codon 12 mutations compared with codon 13 mutations, we ...

Journal: :International journal of oncology 2006
Magdalena C Kraus Matthias H Seelig Ulrich Linnemann Martin R Berger

The aim of this study was to compare the ratio of K-ras codon 12 and 13 mutations in various tissues of colorectal cancer patients. Multiple samples of inconspicuous mucosa and a sample of carcinoma tissue were taken from 36 colorectal cancer patients (group I) and these results were compared with those from polyp and carcinoma tissues of another 48 colorectal cancer patients (group II). A poly...

Journal: :Cancer research 1990
Y Nagata M Abe K Kobayashi K Yoshida T Ishibashi T Naoe E Nakayama H Shiku

Point mutations of c-ras genes were analyzed in human gastrointestinal cancers. DNA obtained from the tissues was amplified by polymerase chain reaction and then analyzed by dot blot hybridization assay with oligonucleotide probes to detect mutations at codons 12, 13, and 61 of c-Ki-ras, c-Ha-ras, and c-N-ras. In two of 25 cases of stomach cancer point mutations at codon 13 of c-Ki-ras were fou...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید